In a depressed patient, the addition of citalopram 40-60 mg per day to treatment with amitriptyline 75 mg per day had no effect on the plasma levels of amitriptyline and nortriptyline, but it led to clinical improvement without the appearance of adverse effects. This and similar findings in four other patients comedicated with citalopram and amitriptyline (2 patients), clomipramine or maprotiline suggest that citalopram differs from other selective serotonin reuptake inhibitors, such as fluvoxamine and fluoxetine, which have been shown to increase tricyclic antidepressant plasma levels
Recent evidence supports the use of second generation antipsychotics in drug resistant depression. T...
From data collected during routine TDM, plasma concentrations of citalopram (CIT) and its metabolite...
Authors compared plasma concentrations of citalopram (CIT) enantiomers and their metabolites in pati...
A depressive patient, a non-responder to trimipramine (TRI), was comedicated first with citalopram (...
The introduction of sensitive methods has rendered possible a multitude of studies on the relationsh...
The authors review the main pharmacological factors playing a role in the kinetics of tricyclic anti...
The effect of comedication with fluvoxamine on the plasma concentrations of the enantiomers of cital...
The relationship between clinical effects and plasma concentrations of citalopram, fluoxetine, clomi...
Citalopram is a chiral antidepressant drug. Its eutomer, S-citalopram (escitalopram), has recently b...
The in vivo pharmacokinetic interaction between two selective serotonin reuptake inhibitors (SSRI) (...
Although often necessary for obtaining remission following major depressive disorder, combined antid...
Citalopram is a selective serotonin reuptake inhibitor used in the treatment of depression. Recent i...
Although a number of more recent substances with fewer side effects have become available for the tr...
A group of 30 patients suffering from endogenous depression was treated with 150 mg amitriptyline (A...
New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned ...
Recent evidence supports the use of second generation antipsychotics in drug resistant depression. T...
From data collected during routine TDM, plasma concentrations of citalopram (CIT) and its metabolite...
Authors compared plasma concentrations of citalopram (CIT) enantiomers and their metabolites in pati...
A depressive patient, a non-responder to trimipramine (TRI), was comedicated first with citalopram (...
The introduction of sensitive methods has rendered possible a multitude of studies on the relationsh...
The authors review the main pharmacological factors playing a role in the kinetics of tricyclic anti...
The effect of comedication with fluvoxamine on the plasma concentrations of the enantiomers of cital...
The relationship between clinical effects and plasma concentrations of citalopram, fluoxetine, clomi...
Citalopram is a chiral antidepressant drug. Its eutomer, S-citalopram (escitalopram), has recently b...
The in vivo pharmacokinetic interaction between two selective serotonin reuptake inhibitors (SSRI) (...
Although often necessary for obtaining remission following major depressive disorder, combined antid...
Citalopram is a selective serotonin reuptake inhibitor used in the treatment of depression. Recent i...
Although a number of more recent substances with fewer side effects have become available for the tr...
A group of 30 patients suffering from endogenous depression was treated with 150 mg amitriptyline (A...
New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned ...
Recent evidence supports the use of second generation antipsychotics in drug resistant depression. T...
From data collected during routine TDM, plasma concentrations of citalopram (CIT) and its metabolite...
Authors compared plasma concentrations of citalopram (CIT) enantiomers and their metabolites in pati...